Neoadjuvant Chemotherapy Is Effective in Those Infected With SARS-CoV-2: The Real-World Experience of a Large Chinese Breast Cancer Center.
Teng MaTianyi MaLulu WangHaibo WangPublished in: Journal of breast cancer (2024)
With timely treatment and effective medical management, SARS-CoV-2 does not appear to affect the efficacy of NAC; however, it can significantly affect the QOL of patients and increase their psychological distress. Therefore, in addition to a timely assessment of the efficacy of NAC, it is necessary to dynamically understand the patient's psychological state and QOL.
Keyphrases
- sars cov
- neoadjuvant chemotherapy
- end stage renal disease
- transcription factor
- respiratory syndrome coronavirus
- ejection fraction
- newly diagnosed
- chronic kidney disease
- locally advanced
- healthcare
- lymph node
- sentinel lymph node
- peritoneal dialysis
- case report
- prognostic factors
- squamous cell carcinoma
- sleep quality
- patient reported outcomes
- physical activity
- coronavirus disease
- smoking cessation